Physician profile
John H Trimble
NPI 1396733515
$1,451.15
in general payments reported to CMS, 2019-2025
10 companies · $425 in 2025
The $425 reported for 2025 was more than what 91% of Emergency Medical Services providers received nationally (typical 2025 total: $70.35).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2021: $279 · 2022: $146 · 2023: $118 · 2024: $205 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $292.51 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $240.22 | 2022-2025 | Airsupra |
| Mindray Ds USA, INC. | $205.25 | 2024 | Te7 Max, Te X |
| Abbott Laboratories | $164.45 | 2019 | |
| Penumbra, INC. | $141.79 | 2025 | Indigo System |
| Glaxosmithkline, LLC. | $122.10 | 2025 | Nucala |
| Grifols USA, LLC | $121.79 | 2021 | |
| Abbvie INC. | $100.00 | 2023 | Dalvance |
| Pfizer INC. | $63.04 | 2023-2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Trimble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.